The Journal of Organic Chemistry
Article
13.2 Hz, 1H), 4.18 (d, J = 9.5 Hz, 1H), 4.00 and 3.99 (2d, J = 6.6 Hz,
2H), 3.79−3.76 (m, 1H), 3.67 (d, J = 13.2 Hz, 1H), 1.89−1.82 (m,
2H), 1.07 and 1.08 (2t, J = 7.4 Hz, 3H). 13C NMR (125 MHz,
CDCl3): δ 158.9, 156.4, 156.4, 154.1, 153.2, 153.0, 153.0, 147.5, 146.7,
146.5, 146.5, 146.4, 146.4, 146.3, 146.3, 146.3, 146.1, 146.1, 146.1,
146.1, 145.9, 145.7, 145.7, 145.6, 145.6, 145.5, 145.5, 145.5, 145.5,
145.4, 145.34, 145.3, 144.9, 144.8, 144.8, 144.6, 144.5, 143.3, 143.1,
142.8, 142.7, 142.7, 142.7, 142.5, 142.4, 142.3, 142.3, 142.3, 142.3,
142.2, 142.1, 142.0, 141.8, 141.8, 141.7, 140.3, 140.3, 140.2, 140.1,
139.8, 139.8, 139.7, 139.6, 139.6, 138.7, 138.6, 137.2, 137.1, 136.6,
136.2, 135.8, 133.0, 133.0, 132.9, 131.1, 131.1, 131.0, 130.9, 130.3,
129.2, 129.2, 127.8, 127.8, 126.7, 126.7, 121.3, 121.3, 119.7, 119.5,
115.3, 115.2, 114.8, 112.8, 112.8, 80.9, 80.8, 80.8, 76.7, 69.7, 68.8, 68.8,
66.7, 56.3, 51.3, 51.3, 45.3, 45.3, 22.8, 10.8. MALDI-TOF-MS: m/z
1165 (M−). Anal. Calcd for C90H27N3O: C 92.69, H 2.33, N 3.60.
Found: C 92.54, H 2.30, N 3.58.
DHA-C60 Conjugate (3b). A degassed mixture of C60 (108 mg,
0.150 mmol), compound 14 (27 mg, 0.095 mmol), and N-ethylglycine
(105 mg, 1.02 mmol) in toluene (70 mL) was refluxed for 16 h. The
resulting brown solution was allowed to cool, and the solvent was
removed in vacuo. The crude residue was purified by column
chromatography (SiO2, gradient elution from CS2 to 1:4 toluene/CS2)
to give pure the title compound as a flaky brown solid (37 mg, 37%).
Rf = 0.40 (2:3 toluene/CS2). IR (neat) νmax (cm−1): 3029w, 2970s,
2933s, 2250w, 1540m, 1509w, 1186s .1H NMR (500 MHz, CDCl3): δ
7.93 (broad s, 2H), 7.79 (broad d, J = 8.1 Hz, 2H), 6.90 (s, 1H), 6.58−
6.54 (m, 1H), 6.49−6.45 (m, 1H), 6.33−6.28 (m, 2H), 5.82−5.79 (m,
1H), 5.14−5.12 (m, 2H), 4.18 (d, J = 9.4 Hz, 1H), 3.79−3.76 (m,
1H), 3.36−3.29 (m, 1H), 2.69−2.62 (m, 1H), 1.56 − 1.49 (m, 3H).
13C NMR (125 MHz, CDCl3): δ 156.5, 156.5, 154.3, 153.3, 153.1,
153.0, 147.5, 147.5, 146.7, 146.6, 146.5, 146.4, 146.4, 146.3, 146.3,
146.3, 146.1, 146.1, 145. 9, 145.7, 145.7, 145.6, 145.5, 145.5, 145.4,
145.4, 145.3, 144.9, 144.8, 144.6, 143.3, 143.1, 142.9, 142.7, 142.7,
142.7, 142.5, 142.4, 142.3, 142.3, 142.3, 142.2, 142.1, 142.1, 142.0,
141.8, 141.7, 141.7, 140.4, 140.3, 140.2, 140.1, 139.9, 139.8, 139.8,
138.8, 138.7, 137.2, 137.2, 136.7, 136.1, 135.8, 132.9, 132.8, 131.1,
131.1, 131.0, 130.7, 130.4, 130.4, 130.4, 127.8, 127.8, 126.6, 121.2,
121.2, 119.6, 119.5, 115.3, 115.2, 112.8, 112.8, 81.9, 81.9, 76.7, 69.1,
66.6, 51.3, 51.3, 47.4, 13.5. Anal. Calcd for C82H19N3: C 94.15, H 1.83,
N 4.02. Found: C 94.02, H 1.77, N 3.98.
2-{4-[2-(4-Formylphenyl)ethynyl]phenyl}-1,8a-dihydroazu-
lene-1,1-dicarbonitrile (17). To a degassed stirring solution of
compound 2 (352 mg, 0.92 mmol) and 4-ethynylbenzaldehyde (15)
(175 mg, 1.35 mmol) in a solvent mixture of THF (20 mL) and
diisopropylamine (20 mL) were added sequentially CuI (21 mg, 0.11
mmol) and Pd(PPh3)4 (75 mg, 0.065 mmol). The mixture was stirred
in the dark for 1 h. The solvent was removed in vacuo, and the crude
material was purified by flash column chromatography (SiO2, gradient
elution from toluene to 1:19 EtOAc/toluene) and chromatographed a
second time (SiO2, CH2Cl2) to afford the title compound as a bright
yellow solid (265 mg, 75%). Mp 185−187 °C (decomp). Rf = 0.34
(3:7 THF/heptane). IR (ATR) νmax (cm−1): 3028w, 2834w, 2737w,
2244vw, 2211w, 2151vw, 1686s, 1594s, 1558m, 1515m, 1436w,
1411m, 1388m, 1363w. 1H NMR (500 MHz, CDCl3): δ 10.04 (s, 1H),
7.90−7.88 (m, 2H), 7.76−7.74 (m, 2H), 7.71−7.69 (m, 2H), 7.65−
7.63 (m, 2H), 6.94 (s, 1H), 6.59 (dd, J = 11.4, 5.9 Hz, 1H), 6.50 (dd, J
= 11.4, 6.1 Hz, 1H). 6.39 (broad d, J = 5.9 Hz, 1H), 6.33 (ddd, J =
10.2, 6.1, 2.1 Hz, 1H), 5.83 (dd, J = 10.2, 3.8 Hz, 1H), 3.81 (ddd, J =
3.8, 2.1, 2.1 Hz, 1H). 13C NMR (125 MHz, CDCl3): δ 191.5, 139.3,
138.6, 135.8, 133.4, 132.7, 132.4, 131.5, 131.0, 130.8, 129.8, 129.2,
127.9, 126.3, 124.3, 121.8, 119.6, 115.1, 112.7, 92.7, 91.2, 51.3
(doublet signal due to incomplete decoupling), 45.17. MALDI-TOF-
MS: m/z 384 (M−). Anal. Calcd for C27H16N2O: C 84.36, H 4.20, N
7.29. Found: C 84.44, H 4.31, N 7.33.
mg, 0.029 mmol). The resulting mixture was stirred in the dark for 2 h.
The solvent was removed under reduced pressure, and the crude
material was purified by flash column chromatography (SiO2, gradient
elution from toluene to 1:19 EtOAc/toluene) and chromatographed a
second time (SiO2, CH2Cl2) to give the product (156 mg, 60%) as a
bright yellow solid. Mp 215−225 °C (decomp). Rf = 0.35 (3:7 THF/
heptane). IR (ATR) νmax (cm−1): 3043w, 3001vw, 2829w, 2730w,
2205w, 2158vw, 1701s, 1598m, 1579sh, 1559w, 1513m, 1431w,
1408m, 1381w. 1H NMR (500 MHz, CDCl3): δ 10.03 (s, 1H), 7.89−
7.87 (m, 2H), 7.75−7.72 (m, 2H), 7.70−7.68 (m, 2H), 7.64−7.61 (m,
2H), 7.56 (s, 4H), 6.93 (s, 1H), 6.59 (dd, J = 11.3, 6.2 Hz, 1H), 6.50
(dd, J = 11.3, 6.0 Hz, 1H), 6.38 (broad d, J = 6.2 Hz, 1H), 6.32 (ddd, J
= 10.2, 6.0, 2.1 Hz, 1H), 5.83 (dd, J = 10.2, 3.9 Hz, 1H), 3.81 (ddd, J =
3.9, 2.1, 2.1 Hz, 1H). 13C NMR (125 MHz, CDCl3): δ 191.5, 139.4,
138.6, 135.7, 133.2, 132.5, 132.3, 131.9, 131.9, 131.4, 131.0, 130.5,
129.4, 127.9, 126.3, 124.7, 123.6, 122.8, 121.7, 119.6, 115.1, 112.7,
93.1, 91.8, 91.2, 90.7, 51.3 (doublet due to incomplete decoupling),
45.2. MALDI-TOF-MS: m/z 484 (M−). Anal. Calcd for C35H20N2O:
C 86.76, H 4.16, N 5.78. Found: C 86.81, H 4.12, N 5.84.
DHA-C60 Conjugate (4). Method 1, Prato reaction. A degassed
mixture of C60 (313 mg, 0.434 mmol), compound 17 (62 mg, 0.161
mmol), and 2-(4-propyloxybenzyl amino)acetic acid (9) (212 mg,
0.910 mmol) in toluene (150 mL) was heated to reflux for 12 h. The
solvent was removed in vacuo, and the crude residue was subjected to
column chromatography (SiO2, gradient elution from CS2 to 3:7
toluene/CS2) to afford the title compound as a dark brown solid (93
mg, 46%). Rf = 0.36 (3:7 toluene/CS2). Method 2, Sonogashira cross-
coupling reaction. A degassed solution of dry NEt3 (2 mL) in toluene
(10 mL) was added via cannula to fulleropyrrolidine aryl-iodide (21)
(13.4 mg, 0.012 mmol), Pd(PPh3)4 (1.4 mg, 0.001 mmol), CuI (0.3
mg, 0.001 mmol), and 25 (17 mg, 0.06 mmol). After 7 h of stirring at
90 °C, the solvent was removed under reduced pressure. The crude
material was purified by column chromatography (SiO2, gradient
elution from CS2 to CH2Cl2) to yield pure title compound as a dark
brown solid (5.1 mg, 33%). IR (ATR) νmax (cm−1): 3017w, 2858w,
2914w, 2867w, 2779w, 1739m, 1602w, 1580w, 1540w, 1507s, 1460m,
1423m, 1409sh, 1372m, 1353 m. 1H NMR (500 MHz, CDCl3): δ 7.95
(broad s, 2H), 7.74−7.71 (m, 2H), 7.65 (broad d, J = 8.1 Hz, 2H),
7.62−7.59 (m, 2H), 7.56−7.54 (m, 2H), 7.04−7.01 (m, 2H), 6.91 (s,
1H), 6.57 (dd, J = 11.3, 5.9 Hz, 1H), 6.49 (dd, J = 11.3, 6.1 Hz, 1H),
6.36 (broad d, J = 5.9 Hz, 1H), 6.31 (ddd, J = 10.2, 6.1, 2.1 Hz, 1H),
5.82 (dd, J = 10.2, 3.8 Hz, 1H), 5.19 (s, 1H), 4.85 (d, J = 9.5 Hz, 1H),
4.49 (d, J = 13.2 Hz, 1H), 4.17 (d, J = 9.5 Hz, 1H), 4.00 (t, J = 6.6 Hz,
2H), 3.79 (ddd, J = 3.8, 2.1, 2.1 Hz, 1H), 3.67 (d, J = 13.2 Hz, 1H),
1.91−1.80 (m, 2H), 1.08 (t, J = 7.4 Hz, 3H). 13C NMR (125 MHz,
CDCl3): δ 158.9, 156.4, 154.2, 153.3, 153.2, 147.5, 146.8, 146.5, 146.5,
146.4, 146.4, 146.3, 146.3, 146.3, 146.2, 146.1, 146.1, 145.9, 145.7,
145.7, 145.5, 145.4, 145.4, 145.3, 144.9, 144.8, 144.6, 144.5, 143.3,
143.1, 142.8, 142.7, 142.7, 142.7, 142.5, 142.4, 142.3, 142.3, 142.2,
142.2, 142.0, 142.0, 141.8, 141.7, 140.3, 140.3, 140.1, 139.7, 139.5,
138.6, 138.1, 137.1, 136.6, 136.1, 135.8, 133.0, 132.5, 132.3, 131.3,
131.0, 130.3, 130.2, 129.3, 127.9, 126.3, 125.0, 123.1, 121.6, 119.6,
115.1, 114.8, 112.7, 92.1, 89.6, 81.0, 76.7, 69.7, 68.8, 66.6, 56.2, 51.3,
51.2, 45.1, 22.8, 10.8. MALDI-TOF-MS: m/z 1265 (M−). Anal. Calcd
for C98H31N3O: C 92.95, H 2.47, N 3.32. Found: C 92.80, H 2.39, N
3.26.
DHA-C60 Conjugate (5). A degassed mixture consisting of C60
(278 mg, 0.386 mmol), compound 18 (81 mg, 0.167 mmol), and 2-(4-
propyloxybenzyl amino)acetic acid (9) (353 mg, 1.52 mmol) in
toluene (150 mL) was heated to reflux for 12 h. The solvent was
removed in vacuo, and the crude residue was subjected to column
chromatography (SiO2, gradient elution from CS2 to 3:7 toluene/CS2)
to afford the title compound as a dark brown solid (102 mg, 45%). Rf
= 0.38 (3:7 toluene/CS2). IR (ATR) νmax (cm−1): 3019w, 2962w,
2913w, 2868w, 2778w, 1602m, 1581sh, 1507s, 1461m, 1423m, 1409m,
2-{4-[2-(4-(2-(4-Formylphenyl)ethynyl)phenyl)ethynyl]-
phenyl}-1,8a-dihydroazulene-1,1-dicarbonitrile (18). To a de-
gassed stirring solution of compound 2 (205 mg, 0.54 mmol) and 4-
[(4-ethynylphenyl)ethynyl]benzaldehyde (16) (173 mg, 0.75 mmol)
in a solvent mixture of THF (15 mL) and diisopropylamine (10 mL)
were added sequentially CuI (10 mg, 0.053 mmol) and Pd(PPh3)4 (33
1
1372m, 1352w. H NMR (500 MHz, CDCl3): δ 7.94 (broad s, 2H),
7.74−7.71 (m, 2H), 7.65 (broad d, J = 8.1 Hz, 2H), 7.62−7.59 (m,
2H), 7.56−7.50 (m, 6H), 7.04−7.01 (m, 2H), 6.92 (s, 1H), 6.58 (dd, J
= 11.2, 5.9 Hz, 1H), 6.49 (dd, J = 11.2, 6.1 Hz, 1H), 6.37 (broad d, J =
5.9 Hz, 1H), 6.32 (ddd, J = 10.2, 6.1, 2.1 Hz, 1H), 5.83 (dd, J = 10.2,
8929
dx.doi.org/10.1021/jo301306y | J. Org. Chem. 2012, 77, 8922−8932